Loading
Latest filing published 17 Mar 2021 for Sorrento Therapeutics, Inc..
No signal scores available.
One trade, one date: on 17 March 2021, Najjam Asghar disclosed a share grant in Sorrento Therapeutics, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration